SCHEMBL31301426

SCHEMBL31301426

CCc1ccc(-c2cncc(C(=O)N(C)c3ccc(Cl)cc3)c2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN10A Q9Y5Y9 6/20 0.47
SCN2A Q99250 5/20 0.47
MAP4K4 O95819 1/20 0.45
CCNC P24863 1/20 0.43
CDK8 P49336 1/20 0.43
GPBAR1 Q8TDU6 4/20 0.42
CYP1A1 P04798 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2E1 P05181 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C8 P10632 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2A6 P11509 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP4B1 P13584 1/20 0.42
CYP2B6 P20813 1/20 0.42
CYP3A5 P20815 1/20 0.42
CYP2A7 P20853 1/20 0.42
CYP3A7 P24462 1/20 0.42
CYP2F1 P24903 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31301417 0.91 MAP4K4 (0.52) SCN10ASCN2AMAP4K4CCNCCDK8
SCHEMBL31301548 0.86 SCN10A (0.54) SCN10ASCN2AMAP4K4GPBAR1CHEK2
SCHEMBL31301503 0.84 SCN10A (0.46) SCN10ASCN2AMAP4K4CCNCCDK8
SCHEMBL31301568 0.82 GPBAR1 (0.54) SCN10ASCN2AMAP4K4GPBAR1
SCHEMBL31301555 0.81 GPBAR1 (0.54) SCN10ASCN2AMAP4K4GPBAR1CYP1A1
SCHEMBL31301259 0.78 HTT (0.50) GPBAR1CHEK2SMN1; SMN2ALDH1A1MAPT
SCHEMBL31301439 0.78 GPBAR1 (0.53) SCN10ASCN2AGPBAR1CYP3A4CYP2C19
SCHEMBL31301415 0.78 SCN10A (0.52) SCN10ASCN2AGPBAR1CYP1A1CYP1A2
SCHEMBL31301583 0.75 GPBAR1 (0.47) SCN10ASCN2AMAP4K4GPBAR1
SCHEMBL486192 0.73 SLC22A12 (0.44) CCNCCDK8SMN1; SMN2ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4727549-A2 PLASMODIUM FALCIPARUM BLOOD STAGE INHIBITORS University of Georgia Research Foundation, Inc. (US) 2026-04-22 EP disclosed
US-20260097046-A1 PLASMODIUM FALCIPARUM BLOOD STAGE INHIBITORS UNIV GEORGIA (US) 2026-04-09 US disclosed
WO-2024258900-A2 PLASMODIUM FALCIPARUM BLOOD STAGE INHIBITORS UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2024-12-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260097046-A1 PLASMODIUM FALCIPARUM BLOOD STAGE INHIBITORS SUB1, PFN1, HCCS SCN10A 3171/4885SCN2A 2686/4885MAP4K4 4387/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.